The Patent Finder

Richter Gedeon Nyrt.

Also on record
Records under this name other than the patents Richter Gedeon Nyrt. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 42 patents it holds.

Back to Richter Gedeon Nyrt.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,450,476Process for the Preparation of 17-Hydroxy-6beta,7beta;15beta,16beta-Bismethylene-17alpha-Pregn-4-Ene-3-One-21-Carboxylic Acid gamma-Lactone and Key Intermediates for this Process
Held by another company
In force
 · High confidence
In forceHigh confidence
US 8,309,712Industrial Process for the Preparation of 17-Hydroxy-6BETA,7BETA;15BETA,16BETA-BISMETHYLENE-3-OXO-17ALPHA-PREGN-4-ENE-21-Carboxylic Acid Gamma-Lactone and Key Intermediates for This Process
Held by another company
In force
 · High confidence
In forceHigh confidence
US 9,994,525H3 Antagonists Containing Phenoxypiperidine Core Structure
Lapsed on the fee record
Ended Jun 12, 2026 · High confidence
Lapsed on the fee recordEnded Jun 12, 2026High confidence
US 11,274,119Industrial process for the synthesis of nomegestrol-acetate
Lapsed on the fee record
Ended Mar 15, 2026 · USPTO record
Lapsed on the fee recordEnded Mar 15, 2026USPTO record
US 11,091,436Process for the separation of optical isomers of racemic 3-alkylpiperidine-carboxylic acid ethyl esters
Lapsed on the fee record
Ended Aug 17, 2025 · USPTO record
Lapsed on the fee recordEnded Aug 17, 2025USPTO record
US 9,717,691Pharmaceutical containing a hormone combination having a contraceptive effect and an insulin sensitizer
Lapsed on the fee record
Ended Aug 1, 2025 · USPTO record
Lapsed on the fee recordEnded Aug 1, 2025USPTO record
US 9,683,010Process for the production of 21-methoxy-11-beta-phenyl-19-nor-pregna-4,9-diene-3,20-dione derivatives
Lapsed on the fee record
Ended Jun 20, 2025 · USPTO record
Lapsed on the fee recordEnded Jun 20, 2025USPTO record
US 7,435,744Piperdine Derivatives as Nmda Receptor Antagonists
Formerly held
Term ended
Term ended Nov 5, 2024 · High confidence
Term endedTerm ended Nov 5, 2024High confidence
US 9,458,207Methods for refolding G-CSF from inclusion bodies
Lapsed on the fee record
Ended Oct 4, 2024 · USPTO record
Lapsed on the fee recordEnded Oct 4, 2024USPTO record
US 9,416,164Method for the production of polypeptides
Lapsed on the fee record
Ended Aug 16, 2024 · USPTO record
Lapsed on the fee recordEnded Aug 16, 2024USPTO record
10 of 34 patents shown.
Pro members see all 34.
Pro members: see all 34 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited